BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6008165)

  • 1. Effect of tranylcypromine and iproniazid on brain amine levels and ovulation in the golden hamster.
    Alleva JJ; Overpeck JG; Umberger EJ
    Life Sci; 1966 Sep; 5(17):1557-61. PubMed ID: 6008165
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for neural control of the release of pituitary ovulating hormone in the golden syrian hamster.
    Alleva JJ; Umberger EJ
    Endocrinology; 1966 Jun; 78(6):1125-9. PubMed ID: 5950761
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of iproniazid and tranyleypromine studied with a dark-avoidance conditioned schedule.
    Bucci L; Bovet D
    Psychopharmacologia; 1974 Feb; 35(2):179-88. PubMed ID: 4815117
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain levels of serotonin (5-HT) and norepinephrine (NE) during mescaline-induced behavior in mice.
    Shah NS
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):201-4. PubMed ID: 4686103
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of bacterial lipopolysaccharide on the content of serotonin and norepinephrine in rabbit brain.
    Takagi H; Kuruma I
    Jpn J Pharmacol; 1966 Dec; 16(4):478-9. PubMed ID: 5342289
    [No Abstract]   [Full Text] [Related]  

  • 6. [The action mechanism of the monoaminoxidase inhibitors on the nervous regulation of the coronary circulation].
    Kaverina NV; Mirzoian RS; Rozonov IuB
    Farmakol Toksikol; 1965; 28(6):689-94. PubMed ID: 5876367
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
    Stahl SM; Narotzky RA; Boshes B; Zeller EA
    Biol Psychiatry; 1974 Dec; 9(3):295-323. PubMed ID: 4441577
    [No Abstract]   [Full Text] [Related]  

  • 8. The inverse relationship between the activity of pyridoxal kinase and the level of biogenic amines in rabbit brain.
    Ebadi MS; Russell RL; McCoy EE
    J Neurochem; 1968 Jul; 15(7):659-65. PubMed ID: 5302709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of monoamine oxidase inhibitors on the content of catecholamines in different parts of the brain in cats].
    Vysotskaia NB; Kaverina NV; Mirzoian RS; Rozonov IuB
    Farmakol Toksikol; 1967; 30(3):289-92. PubMed ID: 5597732
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 11. Alterations of monoamine content by decaborane after monoamine oxidase inhibition by iproniazid. SAM-TR-67-72.
    Merritt JH; Sulkowski TS
    Tech Rep SAM-TR; 1967 Jul; ():1-6. PubMed ID: 5301200
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetics of audiogenic seizures: II. Effects of pharmacological manipulation of brain serotonin, norepinephrine and gamma-aminobutyric acid.
    Schlesinger K; Boggan W; Freedman DX
    Life Sci; 1968 Apr; 7(7):437-47. PubMed ID: 4385105
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of iprazid and transamine on cerebral circulation and the concentrations of gamma-aminobutyric, glutamic and aspartic acids in the tissues of the walls of the cerebral vessels].
    Mirzoian SA; Paglavian VG
    Farmakol Toksikol; 1972; 35(6):698-700. PubMed ID: 4651803
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of some N-substituted eleostearic acid hydrazides as potential monoamine oxidase inhibitors.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1973 May; 16(5):450-2. PubMed ID: 4146252
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of alpha-methyldopa, reserpine, guanethidine, and iproniazid on minimum alveolar anesthetic requirement (MAC).
    Miller RD; Way WL; Eger EI
    Anesthesiology; 1968; 29(6):1153-8. PubMed ID: 5726752
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebral amines and acute hyperbaric oxygen toxicity.
    Blenkarn GD; Schanberg SM; Saltzman HA
    J Pharmacol Exp Ther; 1969 Apr; 166(2):346-53. PubMed ID: 5776990
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of pharmacological agents and fasting on pancreatic islet norepinephrine in the golden hamster.
    Feldman JM; Henderson JH; Blalock JA
    Diabetologia; 1979 Sep; 17(3):169-74. PubMed ID: 389724
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    MaƮtre L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.